ASBP
Aspire Biopharma·NASDAQ
--
--(--)
--
--(--)
1.33 / 10
Underperform
Technically, ASBP is underperforming with a 1.33/10 score. Dominant bearish signals—long lower shadow, MACD golden cross failure, and long upper shadow—suggest downward pressure. The absence of bullish indicators reinforces a defensive posture until clearer trend reversal occurs.
Analysis Checks(0/3)
Long Lower Shadow
Score1/10
Win Rate41.03%
Hist. Signals117
Avg Return-3.91%
Score1/10
Win Rate41.03%
Hist. Signals117
Avg Return-3.91%
MACD Golden Cross
Score1/10
Win Rate20.00%
Hist. Signals5
Avg Return-6.47%
Score1/10
Win Rate20.00%
Hist. Signals5
Avg Return-6.47%
Long Upper Shadow
Score2/10
Win Rate43.52%
Hist. Signals108
Avg Return-0.06%
Score2/10
Win Rate43.52%
Hist. Signals108
Avg Return-0.06%
Long Lower Shadow
Score1/10
Win Rate41.03%
Hist. Signals117
Avg Return-3.91%
Score1/10
Win Rate41.03%
Hist. Signals117
Avg Return-3.91%
Long Upper Shadow
Score2/10
Win Rate43.52%
Hist. Signals108
Avg Return-0.06%
Score2/10
Win Rate43.52%
Hist. Signals108
Avg Return-0.06%
MACD Golden Cross
Score1/10
Win Rate20.00%
Hist. Signals5
Avg Return-6.47%
Score1/10
Win Rate20.00%
Hist. Signals5
Avg Return-6.47%
Technical Analysis of ASBP?
- ASBP presents a Underperform setup with a Technical Score of 1.33/10. Key technical indicators highlight an RSI of 35.00 and a MACD of 0.08, with the trend anchored by the 50-Day SMA at 3.33. Traders should monitor key support at 1.21 and resistance at 1.49.
